Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
10 Things You Should Know About Cerebral Amyloid Angiopathy
Stroke 57:e69-e742026, Charidimou,A.,